Clinical Trial Update: Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing irinotecan plus 5-FU/leucovorin versus 5-FU/leucovorin after liver resection in colorectal cancer completed; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Pfizer | Conditions: Colorectal Neoplasms, Liver Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2009-06-01